BLRX
BioLineRx Ltd
NASDAQ: BLRX · HEALTHCARE · BIOTECHNOLOGY
$2.79
-9.12% today
Updated 2026-04-30
Market cap
$10.21M
P/E ratio
0.00
P/S ratio
8.66x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$2 – $8
Volume
0.0M
BioLineRx Ltd (BLRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-4.3%
Last 4 quarters
Revenue YoY growth
-98.3%
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.9%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.7%
2026-03-23
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-23 | $-0.32 | +58.4% | $2.65 | $2.42 | -8.7% |
| 2025-11-13 | $-0.23 | +58.2% | $3.48 | $3.23 | -7.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.77 | $-0.32 | +58.4% | $195211.00 | -98.3% |
| 2025-09-30 | $-0.54 | $-0.23 | +58.2% | $427000.00 | -91.4% |
| 2025-06-30 | $-0.53 | $-1.02 | -92.2% | $304000.00 | -94.4% |
| 2025-03-31 | $-1.06 | $-1.50 | -41.6% | $255000.00 | -96.3% |
| 2024-12-31 | $-0.03 | $0.00 | +100.0% | $11.75M | +144.8% |
| 2024-09-30 | $-4.40 | $-0.07 | +98.3% | $4.94M | — |
| 2024-06-30 | $-0.14 | $0.01 | +104.4% | $5.39M | — |
| 2024-03-31 | $-0.29 | $-0.01 | +96.6% | $6.86M | — |
| 2023-12-31 | $-0.16 | $-0.15 | +6.3% | $4.80M | — |
| 2023-09-30 | $-0.21 | $-0.01 | +95.2% | — | — |
| 2023-06-30 | $-0.11 | $-0.30 | -172.7% | — | — |
| 2023-03-31 | $-0.17 | $-0.15 | +11.8% | — | — |
Frequently asked questions
Has BioLineRx Ltd beaten earnings estimates?
BioLineRx Ltd has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -4.3% over the last 4 quarters.
How does BLRX stock react to earnings?
BLRX stock has moved an average of -7.9% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is BioLineRx Ltd's revenue growth rate?
BioLineRx Ltd reported year-over-year revenue growth of -98.3% in its most recent quarter.